• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.

作者信息

Ohanian S H, Schlager S I

出版信息

Crit Rev Immunol. 1981 Jan;1(3):165-209.

PMID:6174273
Abstract

The killing or lysis of nucleated cells, erythrocytes, bacteria, and other targets (e.g., liposomes) by antibody and complement is the result of complex series of actions and interactions between antibody, components of the complement system, and the cell. The complement attack mechanism has strict qualitative and quantitative requirements. For efficient activity, sufficient amounts of antibody must bind to the cell, the antibody must be of the complement-fixing type, and sufficient amounts of complement components must be activated and fixed to the surface of the target cells. Nucleated cells of different types differ in their sensitivity to the cytotoxic action of complement. This difference in sensitivity may be attributed to differences in metabolic properties and/or the chemical and physical composition of the cells. Since complement action occurs primarily on or in the cell membrane, the properties of the cell which may affect the outcome of complement-mediated attack should be linked to cell membrane function and integrity. The relationship between the susceptibility of nucleated cells to complement-mediated killing and the chemical and metabolic properties of the cells will be discussed in this review.

摘要

相似文献

1
Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.
Crit Rev Immunol. 1981 Jan;1(3):165-209.
2
Plasma membrane and intracellular lipid synthesis in tumor cells rendered resistant to humoral immune killing after treatment with hormones.
J Natl Cancer Inst. 1980 Apr;64(4):943-50.
3
Effect of specific phospholipids on the antibody-complement-mediated killing of nucleated cells.特定磷脂对抗体补体介导的有核细胞杀伤作用的影响。
J Immunol. 1979 Sep;123(3):1014-9.
4
Homologous species restriction of the complement-mediated killing of nucleated cells.补体介导的有核细胞杀伤的同源物种限制。
Immunology. 1990 Aug;70(4):422-6.
5
Correlation between the ability of tumor cells to incorporate specific fatty acids and their sensitivity to killing by a specific antibody plus guinea pig complement.
J Natl Cancer Inst. 1978 Sep;61(3):931-4.
6
Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement.抑制肿瘤细胞的DNA、RNA和蛋白质合成对其被抗体和补体杀伤敏感性的影响。
Cancer Res. 1977 May;37(5):1432-7.
7
Distinct restriction of complement- and cell-mediated lysis.补体介导的溶解和细胞介导的溶解的明显限制。
J Immunol. 1989 Jun 1;142(11):3913-6.
8
Nucleated cell killing by complement: effects of C5b-9 channel size and extracellular Ca2+ on the lytic process.补体对有核细胞的杀伤作用:C5b-9通道大小和细胞外Ca2+对溶解过程的影响。
J Immunol. 1987 Mar 1;138(5):1530-6.
9
The indiction by complement of a change in KSCN-dissociable red cell membrane lipids.补体对硫氰酸钾可解离红细胞膜脂质变化的指示作用。
J Immunol. 1976 Apr;116(4):1163-9.
10
Antibody-mediated cell cytotoxicity in a defined system: regulation by antigen, antibody, and complement.特定系统中抗体介导的细胞毒性:受抗原、抗体和补体的调节。
J Immunol. 1976 Jan;116(1):253-60.

引用本文的文献

1
How Do mAbs Make Use of Complement to Kill Cancer Cells? The Role of Ca.单克隆抗体如何利用补体来杀死癌细胞?钙的作用。
Antibodies (Basel). 2020 Sep 4;9(3):45. doi: 10.3390/antib9030045.
2
High-resolution structures of the IgM Fc domains reveal principles of its hexamer formation.IgM Fc 结构域的高分辨率结构揭示了其六聚体形成的原理。
Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10183-8. doi: 10.1073/pnas.1300547110. Epub 2013 Jun 3.
3
Complement activation and cardiac surgery: a novel target for improving outcomes.补体激活与心脏手术:改善预后的新靶点。
Anesth Analg. 2012 Oct;115(4):759-71. doi: 10.1213/ANE.0b013e3182652b7d. Epub 2012 Jul 13.
4
Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.小细胞肺癌相关自身抗体:在癌症诊断、早期检测和治疗中的潜在应用。
Mol Cancer. 2011 Mar 30;10:33. doi: 10.1186/1476-4598-10-33.
5
Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid.人类癌细胞的补体抗性取决于膜调节蛋白、蛋白激酶和唾液酸。
Clin Exp Immunol. 2003 Feb;131(2):254-63. doi: 10.1046/j.1365-2249.2003.02066.x.
6
Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis.细胞外信号调节激酶(ERK)丝裂原活化蛋白激酶参与细胞对补体介导的细胞溶解的抗性。
Clin Exp Immunol. 2001 Mar;123(3):366-74. doi: 10.1046/j.1365-2249.2001.01477.x.
7
Mechanisms of complement resistance induced by non-lethal complement attack and by growth arrest.由非致死性补体攻击和生长停滞诱导的补体抗性机制。
Immunology. 1997 Apr;90(4):647-53. doi: 10.1046/j.1365-2567.1997.00197.x.
8
Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics.补体对有核细胞的细胞溶解作用:细胞死亡表现出多次打击特征。
Proc Natl Acad Sci U S A. 1983 Jun;80(12):3816-20. doi: 10.1073/pnas.80.12.3816.
9
Role of membrane lipids in the immunological killing of tumor cells: I. Target cell lipids.膜脂在肿瘤细胞免疫杀伤中的作用:I. 靶细胞脂质
Lipids. 1983 Jul;18(7):475-82. doi: 10.1007/BF02535788.
10
The membrane attack complex.膜攻击复合物
Springer Semin Immunopathol. 1984;7(2-3):93-141. doi: 10.1007/BF01893017.